Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Hemophilia A”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT02035605
What this trial is testing

An Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Who this might be right for
Hemophilia AHemophilia B
Sanofi 51
Large-scale testing (Phase 3)Study completedNCT03528551
What this trial is testing

A Research Study Looking at How a Factor VIII Medicine Called Turoctocog Alfa Pegol (N8-GP) Works in People With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 160
Not applicableUnknownNCT01623960
What this trial is testing

Quality of Life in Adult Patients With Severe Haemophilia in Turkey

Who this might be right for
Haemophilia
Turkish Society of Hematology 500
Post-approval studies (Phase 4)UnknownNCT06320626
What this trial is testing

Pharmacokinetic-guided Dosing of Emicizumab

Who this might be right for
Hemophilia A With InhibitorHemophilia A Without InhibitorHemophilia A, Severe+3 more
Kathelijn Fischer 95
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06747416
What this trial is testing

KN057 Multiple Dose Study in Patients with Hemophilia a or Hemophilia B with or Without Inhibitors

Who this might be right for
Hemophilia a and B
Suzhou Alphamab Co., Ltd. 24
Not applicableNot Yet RecruitingNCT07418827
What this trial is testing

Determinants and Consequences of the Transition to Adulthood for Adolescents With Severe Haemophilia: TRANSHEMO 2, an Ancillary Study to the TRANSHEMO Project

Who this might be right for
Haemophilia
Assistance Publique Hopitaux De Marseille 75
Large-scale testing (Phase 3)Study completedNCT01488994
What this trial is testing

BAX 326 Pediatric Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 23
Not applicableStudy completedNCT01318707
What this trial is testing

Biomarkers Serum Collection Methodology Pilot Study

Who this might be right for
Hemophilia A
Georgetown University 20
Large-scale testing (Phase 3)Study completedNCT05707351
What this trial is testing

Adynovate in Previously Treated Chinese Teenagers and Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Takeda 37
Post-approval studies (Phase 4)Study completedNCT00323856
What this trial is testing

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A

Who this might be right for
Severe Hemophilia A
Grifols Biologicals, LLC 51
Large-scale testing (Phase 3)Study completedNCT02246881
What this trial is testing

Compare the Pharmacokinetics and Safety of Current Factor VIII Concentrate and Optivate® in Haemophilia A.

Who this might be right for
Von Willebrand Disease
Bio Products Laboratory
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Large-scale testing (Phase 3)Study completedNCT01486927
What this trial is testing

An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A

Who this might be right for
Hemophilia A
CSL Behring 175
Post-approval studies (Phase 4)Study completedNCT03449342
What this trial is testing

Research Study to Look at Side Effects During Regular Injection With Factor VIII Medicine Named Turoctocog Alfa for a 8 Weeks Period

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 60
Not applicableStudy completedNCT05687474
What this trial is testing

Baby Detect : Genomic Newborn Screening

Who this might be right for
Congenital Adrenal HyperplasiaFamilial Hyperinsulinemic Hypoglycemia 1Phosphoglucomutase 1 Deficiency+121 more
Centre Hospitalier Universitaire de Liege 6,824
Not applicableUnknownNCT01626105
What this trial is testing

Personalized Prediction of Tolerance and Immunogenicity in Hemophilia

Who this might be right for
Hemophilia A
Victor J Marder, M.D. 55
Early research (Phase 1)Study completedNCT01599819
What this trial is testing

BAX 855 Dose-Escalation Safety Study

Who this might be right for
Hemophilia A
Baxalta now part of Shire 19
Not applicableStudy completedNCT01159587
What this trial is testing

Prophylaxis Versus On-demand Therapy Through Economic Report

Who this might be right for
Hemophilia A
Bayer 58
Testing effectiveness (Phase 2)Study completedNCT02554773
What this trial is testing

An Open-label Extension Study of an Investigational Drug, Fitusiran, in Patients With Moderate or Severe Hemophilia A or B

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 34
Not applicableWithdrawnNCT02718677
What this trial is testing

Patient-reported Outcomes in Subjects Treated With ReFacto AF Routine Prophylaxis

Who this might be right for
Hemophilia A
Pfizer
Next Page